Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
LeMaitre Vascular
LMAT
$1.81B
| $2.77M | 0.01% |
227,114
-206,234
| -48% | -$2.64M |
|
|
CBD
1702
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $2.76M | 0.01% |
219,999
-162,932
| -43% | -$3.05M |
|
|
ARIA
1703
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $2.76M | 0.01% |
472,248
-201,005
| -30% | -$1.55M |
|
1704
Globalstar
GSAT
$10.6B
| $2.75M | 0.01% |
116,646
-69,858
| -37% | -$1.97M |
|
1705
Archer Daniels Midland
ADM
$38.2B
| $2.75M | 0.01% |
66,244
+37,967
| +134% | +$1.73M |
|
|
SWI
1706
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $2.73M | 0.01% |
69,653
-255,058
| -79% | -$10.5M |
|
|
RTN
1707
CALL
DELISTED
Raytheon Company
RTN
| $2.73M | 0.01% |
+25,000
| New | +$2.61M |
|
|
BUFF
1708
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $2.72M | 0.01% |
+151,920
| New | +$3.73M |
|
|
PVG
1709
DELISTED
PRETIUM RESOURCES INC.
PVG
| $2.72M | 0.01% |
+449,495
| New | +$2.32M |
|
|
SAAS
1710
DELISTED
inContact, Inc.
SAAS
| $2.72M | 0.01% |
361,799
-65,824
| -15% | -$543K |
|
|
SRGA
1711
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $2.71M | 0.01% |
15,919
-14,077
| -47% | -$2.7M |
|
1712
STAG Industrial
STAG
$7.15B
| $2.71M | 0.01% |
148,842
+122,708
| +470% | +$2.31M |
|
1713
TriplePoint Venture Growth BDC
TPVG
$217M
| $2.71M | 0.01% |
267,051
+46,713
| +21% | +$570K |
|
|
DGI
1714
DELISTED
DigitalGlobe Inc.
DGI
| $2.7M | 0.01% |
141,843
-174,825
| -55% | -$4.13M |
|
1715
Costamare
CMRE
$1.91B
| $2.69M | 0.01% |
219,477
-10,704
| -5% | -$169K |
|
|
XIV
1716
DELISTED
VelocityShares Daily Inverse VIX Short Term ETN
XIV
| $2.69M | 0.01% |
+110,364
| New | +$4.1M |
|
1717
State Street Materials Select Sector SPDR ETF
XLB
$8.88B
| $2.68M | 0.01% |
134,398
+35,970
| +37% | +$800K |
|
|
CAM
1718
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $2.68M | 0.01% |
43,735
-1,348,728
| -97% | -$74.4M |
|
1719
Mercury Systems
MRCY
$5.28B
| $2.67M | 0.01% |
167,865
+73,209
| +77% | +$1.11M |
|
|
SAND
1720
DELISTED
Sandstorm Gold
SAND
| $2.67M | 0.01% |
1,000,290
-129,659
| -11% | -$355K |
|
|
TRIB
1721
Trinity Biotech
TRIB
$7.9M
| $2.66M | 0.01% |
1,551
+1,216
| +363% | +$2.94M |
|
1722
CALL
Wynn Resorts
WYNN
$10.2B
| $2.66M | 0.01% |
+50,000
| New | +$4.34M |
|
|
RP
1723
DELISTED
RealPage, Inc.
RP
| $2.65M | 0.01% |
+159,614
| New | +$2.97M |
|
|
RRTS
1724
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $2.64M | 0.01% |
+5,744
| New | +$3.31M |
|
|
ABAX
1725
DELISTED
Abaxis Inc
ABAX
| $2.64M | 0.01% |
59,912
-36,597
| -38% | -$1.8M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.